King’s College London (KCL) and its partner NHS Trusts – King’s College Hospital (KCH) and Guy’s & St Thomas’ Hospital (GSTT) together have one of the largest chimeric antigen receptor T (CAR-T) cell programmes in the UK with licensed and experimental CAR-T products being administered for patients with B-cell leukaemias, lymphomas, multiple myeloma, solid tumours and autoimmune disease. About The Role
This role is to lead GMP manufacturing of CAR-T cells for a Blood Cancer UK funded,...
